CHEYENNE SERRA: Open Payments
NPI 1780254649 · RENSSELAER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,743 in 106 payments from 17 companies in 2025. Trend: 2023 $678 · 2024 $1,199 · 2025 $2,743
Food & beverage: $2,743
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 19 | $1,097 |
| ABBVIE INC. | 12 | $304 |
| PFIZER INC. | 10 | $168 |
| Exact Sciences Corporation | 7 | $160 |
| Sumitomo Pharma America, Inc. | 8 | $154 |
| Novo Nordisk Inc | 6 | $153 |
| Amgen Inc. | 9 | $151 |
| Boston Scientific Corporation | 9 | $141 |
| GlaxoSmithKline, LLC. | 8 | $138 |
| Lilly USA, LLC | 5 | $93 |
Products named: BREZTRI, AIRSUPRA, FARXIGA, QULIPTA, The Cologuard Plus Collection Kit, GEMTESA, General - Pain Management, ELIQUIS.
Industry payments across NY — which companies pay providers there.
